Ergonomics of Sterile CompoundingSunday, December 5, 2021
12:00 p.m.–1:00 p.m. ET
• Explain the role of ergonomics in sterile compounding as it relates to repetitive strain injuries.
• Compare risk factors and practices most prone to repetitive strain injuries in sterile compounding practices.
• Analyze design and automated measures that mitigate injuries using proper ergonomics in sterile compounding.
Patricia C. Kienle, MPA, RPh, BCSCP, FASHP, Director, Accreditation and Medication Safety, Cardinal Health
Dennis A. Tribble, PharmD, BS, Director, Medical Affairs for Innovation, Medication Management Systems, Becton Dickinson, Ormond Beach, Florida
Roundtable: Compounding PracticeSunday, December 5, 2021
1:00 p.m.–2:00 p.m. ET
• USP Chapter <797> proposed revisions
• USP Chapter <800> hazardous drug wipe sampling
• Sterile compounding technician training best practices
Raising the Bar on Sterile Compounding SafetyWednesday, December 8, 2021
1:00 p.m. ET
Sterile compounding is an essential component of pharmacy practice for pharmacists and pharmacy technicians, and efforts to identify and reduce potential adverse events during the preparation of sterile products is imperative to provide safe, optimal patient care.
There has been increased growth and maturity in the compounding technology market and an increased uptake by pharmacies in the use of technology during the sterile compounding process. However, despite advancements, a recent Institute for Safe Medication Practices (ISMP) survey on pharmacy compounding systems and practices revealed there remains an opportunity to improve the safety of sterile compounding practices as well as increase and enhance the safe use of technology in the process.
In September 2021, ISMP convened an invitational, virtual sterile compounding safety summit to specifically address safe practices related to the use of robotic compounding automation, sterile compounding workflow software, and automated compounding devices.
This symposium that will take attendees from the spark that triggered the summit, through the objectives, targets, and structure used to develop new ISMP Best Practice Guidelines, concluding with a discussion of one organization’s journey using various sterile compounding technologies to reduce the risk for errors and the steps they took to minimize threats to safe technology use.
Following completion of this activity, participants will be able to:
• Discuss ISMP survey results regarding sterile compounding.
• List key areas addressed during a recent sterile compounding safety summit.
• Describe safety gaps that exist when using technology to support sterile compounding.
• Identify best practices for the safe use of technology and automation during the compounding process.
« Click here to return to ASHP Conference Connect.